Thompson Davis & Co’s Elanco Animal Health ELAN Stock Holding History

Thompson Davis & Co’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$40K	Buy	+1,150	New	+$40.4K	0.09%	237

Other funds holding ELAN

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Thompson Davis & Co's ELAN Position: Q3 2018 in Review

Thompson Davis & Co opened a new position in Elanco Animal Health (ELAN) in Q3 2018: 1,150 shares worth $40K. The stake represents 0.09% of the portfolio and ranks #237 among its holdings.

153 funds tracked by Wall St. Rank hold ELAN as of Q3 2018.

Thompson Davis & Co held 1,150 shares of Elanco Animal Health worth $40K as of Q3 2018.
Elanco Animal Health was a new Thompson Davis & Co position in Q3 2018.
Elanco Animal Health made up 0.09% of Thompson Davis & Co's portfolio in Q3 2018, its #237 holding.
153 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.